elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q41241298-3D8EA2EE-FD61-4131-A1A1-98E6A1F4B7A2
Q41241298-3D8EA2EE-FD61-4131-A1A1-98E6A1F4B7A2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41241298-3D8EA2EE-FD61-4131-A1A1-98E6A1F4B7A2
Epigenetic dysregulation of ID4 predicts disease progression and treatment outcome in myeloid malignancies.
P2860
Q41241298-3D8EA2EE-FD61-4131-A1A1-98E6A1F4B7A2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41241298-3D8EA2EE-FD61-4131-A1A1-98E6A1F4B7A2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
cfa353fcad3e51cd971fa7b06a859602b320bfbb
P2860
Inhibitor of differentiation 4 (Id4) is a potential tumor suppressor in prostate cancer.